SAN ANTONIO — James Ingle, M.D., an internationally recognized breast cancer expert, will receive the 2014 William L. McGuire Memorial Lecture Award on Dec. 10 at the 2014 San Antonio Breast Cancer Symposium.
Dr. Ingle is a professor of oncology and the Foust Professor in the Mayo Clinic College of Medicine in Rochester, Minnesota. He has been the leader of breast cancer research at the Mayo Clinic Cancer Center, serving as program co-leader of the women's cancer program with responsibility for breast cancer. He is currently co-director of the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE). SPORE grants are funded by the National Cancer Institute (NCI) and are the major NCI translational research grants in which clinicians and basic scientists work together to conduct the most promising research.
Dr. Ingle's research has had a significant impact on clinical practice. He has a long track record of leading or co-leading studies in breast cancer, first with tamoxifen and then with aromatase inhibitors, which are the two major endocrine therapies in breast cancer. More recently, Dr. Ingle has a leadership role in the Mayo Clinic Pharmacogenomic Research Network, leading multiple genome-wide association studies to investigate genetic variability in patients’ response to tamoxifen and aromatase inhibitors as well as chemotherapy. This work is central to developing precision medicine in which the right dose of the right drug is given to the right patient.